A federal judge deciding whether to block a Georgia law that bans hormone replacement therapies for transgender people under 18 said Friday there were “significant interests” on both sides and she would need more time to rule.
During nearly two full days of hearings in Atlanta, Judge Sarah Geraghty heard conflicting testimony from witnesses about the safety and benefits of hormone therapy to treat adolescents with gender dysphoria — the distress felt when someone’s gender expression does not match their gender identity.
![Sarah Geraghty testifies before the Senate Judiciary Committee during her confirmation hearing to be U.S. district judge for the Northern District of Georgia on Dec. 1, 2021. (Photo: Diego M. Radzinschi/ALM)](https://images.law.com/contrib/content/uploads/sites/404/2022/03/Sarah-Geraghty-2021-013-767x633-300x248.jpg)
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]